High VEGF with Rapid Growth and Early Metastasis in a Mouse Osteosarcoma Model
Open Access
- 25 November 2007
- journal article
- research article
- Published by Hindawi Limited in Sarcoma
- Vol. 2007, 1-7
- https://doi.org/10.1155/2007/95628
Abstract
A murine model of osteosarcoma was developed to investigate the association between the expression of VEGF and the progression of osteosarcoma. Two human osteosarcoma cell lines with distinct VEGF expressions were introduced into proximal tibiae of immuno-deficient SCID mice, either by direct injection through the cortical bone or surgical exposing and drilling on the tibial metaphysis to seed tumor cells. Bone tumors were obvious on microCT within 4 weeks following osteosarcoma cell inoculation through surgical delivery. In contrast, direct injection without drilling often resulted in periosteal tumors. Although neoplasms were developed regardless of VEGF levels, orthotopic tumors derived from high VEGF-expressing cells were detected 2 weeks earlier on CT images than the ones from VEGF negative cells. At sacrifice, high VEGF tumors were distinctively larger in size and more frequently invaded the adjacent bone tissue. Multiple metastatic lesions were found in all the lung tissues at 8 weeks from high VEGF group, whereas only 1 of 7 VEGF negative tumors exhibited pulmonary metastasis. Overall, this model developed with the surgical tumor cell delivery results in histological and radiographic features more consistent with primary osteosarcoma. Interestingly, VEGF expression correlates with the early establishment, rapid tumor growth, and the development of pulmonary metastasis.Keywords
Funding Information
- Karmanos Cancer Institute
This publication has 27 references indexed in Scilit:
- An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary MetastasisClinical & Experimental Metastasis, 2005
- Protective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysisGene Therapy, 2004
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- The Myc oncoprotein: a critical evaluation of transactivation and target gene regulationOncogene, 1999
- HORMONE-REFRACTORY PROSTATE CANCER CELLS EXPRESS FUNCTIONAL FOLLICLE-STIMULATING HORMONE RECEPTOR (FSHR)Journal of Urology, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Amplification of c‐myc oncogene and absence of c‐Ha‐ras point mutation in human bone sarcomaJournal of Orthopaedic Research, 1993
- Overexpression of c-fos increases recombination frequency in human osteosarcoma cellsCarcinogenesis: Integrative Cancer Research, 1993
- Vascular Endothelial Growth Factor Is a Secreted Angiogenic MitogenScience, 1989